Join the club for FREE to access the whole archive and other member benefits.

Khosla Ventures

Venture Capital & Private Equity company

Venture Capital & Private Equity company. Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies. The firm was founded in 2004 by Vinod Khosla, co-founder of Sun Microsystems. With over five billion dollars under management, the firm focuses on a broad range of areas including consumer, enterprise, education, advertising, financial services, semiconductors, health, big data, agriculture/food, sustainable energy and robotics. Khosla Ventures is headquartered in Menlo Park, Calif.

Visit website: https://www.khoslaventures.com/

 KhoslaVentures

 khosla-ventures

 khoslaventures

 khoslaventures

Details last updated 29-May-2020

People at Khosla Ventures

Vinod Khosla

Partner at Khosla Ventures

Alexander A. Morgan

Biotechnology, Healthcare, Machine Learning and Partner at Khosla Ventures

Khosla Ventures News

Vivodyne pioneers drug development with lab-grown organs with $38M funding

Vivodyne pioneers drug development with lab-grown organs with $38M funding

Longevity Technology - 22-Nov-2023

Offers over 20 innovative organ models for realistic testing and collaborating

Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies

Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies

Longevity Technology - 07-Sep-2023

A single dose of mRNA therapy could rewind ageing and extend lifespan

Lyfspn recruiting in USA for plasmapheresis trial using 5% human albumin

Lyfspn recruiting in USA for plasmapheresis trial using 5% human albumin

Longevity Technology - 08-Jun-2022

No mention of the Conboys, but it looks like it's based on their plasma dilution research

Ochre Bio secures $9.6M funding for development of RNA therapies

Ochre Bio secures $9.6M funding for development of RNA therapies

Business Wire - 16-Jun-2021

Convergence of genomic technologies and machine learning digitizes liver biology

Fountain secured $6 million Series A-1 financing from Khosla Ventures

Fountain secured $6 million Series A-1 financing from Khosla Ventures

GlobeNewswire - 19-May-2020

With a total of $11 million, more in vivo preclinical drug testing to be expected

Topics mentioned on this page:
Investments